SCHEMBL18553231

SCHEMBL18553231

Clc1nc(-c2ccc(-c3ccccc3)cc2)nc2sc3ccc4ccccc4c3c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 8/20 0.42
▸ HPGD P15428 6/20 0.42
▸ SMN1; SMN2 Q16637 6/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ HTT P42858 3/20 0.40
▸ PTGES O14684 1/20 0.39
▸ LMNA P02545 5/20 0.38
▸ MAPT P10636 4/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ RAB9A P51151 6/20 0.36
▸ CASP3 P42574 2/20 0.36
▸ SENP8 Q96LD8 2/20 0.36
▸ SENP7 Q9BQF6 2/20 0.36
▸ SENP6 Q9GZR1 2/20 0.36
▸ RECQL P46063 1/20 0.35
▸ ADORA2A P29274 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18666497 0.97 NPC1 (0.43) NPC1HPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL18853347 0.85 MEN1 (0.40) NPC1HPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL18853490 0.85 MEN1 (0.40) NPC1HPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL18553249 0.84 ALDH1A1 (0.35) NPC1HPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL18853226 0.82 HPGD (0.40) NPC1HPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL18853319 0.81 ADORA2A (0.39) NPC1HPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL18553242 0.80 NPC1 (0.47) NPC1HPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL18853497 0.80 ADORA2A (0.39) NPC1HPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL18853488 0.80 ADORA2A (0.39) NPC1HPGDSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL18853468 0.79 ADORA2A (0.39) NPC1HPGDSMN1; SMN2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11299459-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2022-04-12 — — US disclosed
WO-2017030307-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS COMPRISING SAME 덕산네오룩스 주식회사 2017-02-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11299459-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, OCIAD1, TMEM109 NPC1 2935/4885HPGD 3589/4885SMN1; SMN2 1388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback